ONWRF
Onward Medical N.V.
Price Chart
Latest Quote
$3.03
| Previous Close | $3.35 |
| Open | $5.50 |
| Day High | $5.50 |
| Day Low | $5.50 |
| Volume | 100 |
Stock Information
| Shares Outstanding | 69.53M |
| Total Debt | $15.67M |
| Cash Equivalents | $78.12M |
| Revenue | $6.21M |
| Net Income | $-47.93M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $210.67M |
| EPS (TTM) | $-1.04 |
| Exchange | OQX |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $115.26M |
| Sales | $6.21M |
| Income | $-47.93M |
| Book/sh | $1.16 |
| Cash/sh | $0.98 |
| Employees | 137 |
Financial Ratios
| Quick Ratio | 6.40 |
| Current Ratio | 6.67 |
| Debt/Eq | 24.70 |
Returns & Margins
| ROA | -31.80% |
| ROE | -80.85% |
| Gross Margin | 80.81% |
| Operating Margin | -494.49% |
Ownership
| Insider Ownership | 28.48% |
| Institutional Ownership | 23.90% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 38.91 |
| P/B | 2.61 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $3.20 |
| SMA50 | $3.37 |
| SMA200 | $4.75 |
| RSI | 41.35 |
| ATR | 0.1205 |
| Shares Float | 43.65M |
| Volatility | 0.85 |
| Rel Volume | 1.04 |
Performance History
| Week | +2.54% |
| Month | -8.18% |
| Quarter | -33.41% |
| 6 Months | -41.17% |
| YTD | -46.37% |
| Year | -33.41% |
| 3 Years | -52.28% |
| 10 Years | -52.28% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $3.03 | 500 |
| 2026-06-17 | $3.35 | 1,500 |
| 2026-06-16 | $2.76 | 180 |
| 2026-06-15 | $3.01 | 0 |
| 2026-06-12 | $3.01 | 5,800 |
| 2026-06-11 | $2.95 | 620 |
| 2026-06-10 | $3.17 | 0 |
| 2026-06-09 | $3.17 | 0 |
| 2026-06-08 | $3.17 | 1,000 |
| 2026-06-05 | $3.30 | 0 |
| 2026-06-04 | $3.30 | 0 |
| 2026-06-03 | $3.30 | 0 |
| 2026-06-02 | $3.30 | 0 |
| 2026-06-01 | $3.30 | 0 |
| 2026-05-29 | $3.30 | 0 |
| 2026-05-28 | $3.30 | 0 |
| 2026-05-27 | $3.30 | 0 |
| 2026-05-26 | $3.30 | 0 |
| 2026-05-22 | $3.30 | 0 |
| 2026-05-21 | $3.30 | 0 |
| 2026-05-20 | $3.30 | 0 |
| 2026-05-19 | $3.30 | 0 |
About Onward Medical N.V.
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven movement of the legs and upper extremities. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
đ° Latest News
Onward Medical NV (ONWRF) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
GuruFocus.com âĸ 2026-05-26T19:00:22ZOnward Medical NV (ONWRF) Full Year 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...
GuruFocus.com âĸ 2026-03-31T19:00:47ZEuropean Penny Stocks To Watch In January 2026
Simply Wall St. âĸ 2026-01-23T11:05:23ZInmocemento Leads The Charge In Our European Penny Stock Spotlight
Simply Wall St. âĸ 2025-12-22T06:04:52ZOnward Medical NV (ONWRF) Q3 2025 Earnings Call Highlights: Revenue Milestone and Strategic ...
GuruFocus.com âĸ 2025-11-24T19:00:29ZLibertas 7 Leads These 3 European Penny Stocks
Simply Wall St. âĸ 2025-11-03T06:04:56ZEU greenlights Onwardâs ARC-EX system for spinal cord injury patients
Medical Device Network âĸ 2025-09-08T12:06:39ZIncome Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $22,000 | $0 | $14,687,000 | $11,980,000 |
| Cost Of Revenue | $22,000 | $0 | $14,687,000 | $11,980,000 |
| Total Revenue | $229,000 | $68,000 | $104,000 | $0 |
| Operating Revenue | $229,000 | $68,000 | $104,000 | $0 |
| Expenses | ||||
| Interest Expense | $1,997,000 | $1,376,000 | $1,515,000 | $5,597,000 |
| Total Expenses | $35,091,000 | $35,531,000 | $32,132,000 | $28,533,000 |
| Net Non Operating Interest Income Expense | $-1,277,000 | $-421,000 | $-1,486,000 | $-5,613,000 |
| Total Other Finance Cost | $71,000 | $17,000 | $33,000 | $17,000 |
| Interest Expense Non Operating | $1,997,000 | $1,376,000 | $1,515,000 | $5,597,000 |
| Operating Expense | $35,069,000 | $35,531,000 | $32,132,000 | $16,553,000 |
| Other Operating Expenses | $3,507,000 | $2,835,000 | $3,875,000 | $993,000 |
| Selling And Marketing Expense | $1,249,000 | $1,113,000 | $1,002,000 | $1,516,000 |
| General And Administrative Expense | $4,429,000 | $5,182,000 | $5,529,000 | $6,241,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-35,725,000 | $-36,181,000 | $-32,772,000 | $-34,314,000 |
| Net Interest Income | $-1,277,000 | $-421,000 | $-1,486,000 | $-5,613,000 |
| Interest Income | $791,000 | $972,000 | $62,000 | $1,000 |
| Normalized Income | $-35,726,992 | $-36,181,000 | $-32,772,000 | $-34,314,000 |
| Net Income From Continuing And Discontinued Operation | $-35,725,000 | $-36,181,000 | $-32,772,000 | $-34,314,000 |
| Total Operating Income As Reported | $-34,862,000 | $-35,463,000 | $-32,028,000 | $-28,532,000 |
| Net Income Common Stockholders | $-35,725,000 | $-36,181,000 | $-32,772,000 | $-34,314,000 |
| Net Income | $-35,725,000 | $-36,181,000 | $-32,772,000 | $-34,314,000 |
| Net Income Including Noncontrolling Interests | $-35,725,000 | $-36,181,000 | $-32,772,000 | $-34,314,000 |
| Net Income Continuous Operations | $-35,725,000 | $-36,181,000 | $-32,772,000 | $-34,314,000 |
| Pretax Income | $-35,765,000 | $-36,074,000 | $-33,538,000 | $-34,245,000 |
| Interest Income Non Operating | $791,000 | $972,000 | $62,000 | $1,000 |
| Operating Income | $-34,862,000 | $-35,463,000 | $-32,028,000 | $-28,533,000 |
| Depreciation And Amortization In Income Statement | $898,000 | $726,000 | $735,000 | $329,000 |
| Depreciation Income Statement | $898,000 | $726,000 | $735,000 | $329,000 |
| Gross Profit | $207,000 | $68,000 | $-14,687,000 | $-11,980,000 |
| Per Share | ||||
| Diluted EPS | $-0.80 | $-1.20 | $-1.09 | $-3.62 |
| Basic EPS | $-0.80 | $-1.20 | $-1.09 | $-3.62 |
| Other | ||||
| Tax Effect Of Unusual Items | $8 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-32,872,000 | $-33,972,000 | $-31,288,000 | $-28,319,000 |
| Total Unusual Items | $2,000 | $0 | - | - |
| Total Unusual Items Excluding Goodwill | $2,000 | $0 | - | - |
| Reconciled Depreciation | $898,000 | $726,000 | $735,000 | $329,000 |
| EBITDA (Bullshit earnings) | $-32,870,000 | $-33,972,000 | $-31,288,000 | $-28,319,000 |
| EBIT | $-33,768,000 | $-34,698,000 | $-32,023,000 | $-28,648,000 |
| Diluted Average Shares | $44,629,000 | $30,184,000 | $30,184,000 | $9,485,000 |
| Basic Average Shares | $44,629,000 | $30,184,000 | $30,184,000 | $9,485,000 |
| Diluted NI Availto Com Stockholders | $-35,725,000 | $-36,181,000 | $-32,772,000 | $-34,314,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Minority Interests | $0 | $0 | $0 | $0 |
| Tax Provision | $-40,000 | $107,000 | $-766,000 | $69,000 |
| Research And Development | $12,442,000 | $13,841,000 | $13,138,000 | $7,932,000 |
| Selling General And Administration | $5,678,000 | $6,295,000 | $6,531,000 | $7,757,000 |
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $37,629,000 | $8,127,000 | $42,473,000 | $72,654,000 |
| Total Assets | $76,137,000 | $43,629,000 | $76,593,000 | $104,796,000 |
| Total Non Current Assets | $12,518,000 | $12,206,000 | $12,417,000 | $12,409,000 |
| Other Non Current Assets | $-1,000 | - | - | - |
| Non Current Deferred Taxes Assets | $568,000 | $310,000 | $163,000 | $0 |
| Goodwill And Other Intangible Assets | $10,425,000 | $9,804,000 | $10,158,000 | $10,029,000 |
| Other Intangible Assets | $8,463,000 | $7,959,000 | $8,256,000 | $8,327,000 |
| Current Assets | $63,619,000 | $31,423,000 | $64,176,000 | $92,387,000 |
| Restricted Cash | $302,000 | $305,000 | $285,000 | $297,000 |
| Prepaid Assets | $2,137,000 | $936,000 | $905,000 | - |
| Inventory | $102,000 | $0 | - | - |
| Other Receivables | $750,000 | $297,000 | $517,000 | $60,000 |
| Taxes Receivable | $125,000 | $117,000 | $709,000 | $339,000 |
| Accounts Receivable | $160,000 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $60,043,000 | $29,768,000 | $61,760,000 | $89,443,000 |
| Cash And Cash Equivalents | $60,043,000 | $29,768,000 | $41,760,000 | $89,443,000 |
| Cash Equivalents | $48,000,000 | $26,200,000 | $20,000,000 | $0 |
| Cash Financial | $12,043,000 | $3,568,000 | $21,760,000 | $89,443,000 |
| Other Current Assets | - | $305,000 | $285,000 | $2,248,000 |
| Debt | ||||
| Total Debt | $15,087,000 | $16,874,000 | $14,377,000 | $13,665,000 |
| Long Term Debt And Capital Lease Obligation | $14,490,000 | $16,306,000 | $13,950,000 | $13,192,000 |
| Long Term Debt | $13,972,000 | $15,255,000 | $12,656,000 | $11,451,000 |
| Current Debt And Capital Lease Obligation | $597,000 | $568,000 | $427,000 | $473,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $28,083,000 | $25,698,000 | $23,962,000 | $22,113,000 |
| Total Non Current Liabilities Net Minority Interest | $18,792,000 | $19,018,000 | $15,741,000 | $16,571,000 |
| Non Current Deferred Taxes Liabilities | $303,000 | $631,000 | $670,000 | $1,991,000 |
| Current Liabilities | $9,291,000 | $6,680,000 | $8,221,000 | $5,542,000 |
| Payables | $6,622,000 | $5,101,000 | $5,734,000 | $4,909,000 |
| Other Payable | $5,009,000 | $3,026,000 | $3,140,000 | $3,748,000 |
| Total Tax Payable | $344,000 | $706,000 | $685,000 | $209,000 |
| Accounts Payable | $1,269,000 | $1,369,000 | $1,909,000 | $952,000 |
| Other Non Current Liabilities | - | - | - | $1,000 |
| Equity | ||||
| Common Stock Equity | $48,054,000 | $17,931,000 | $52,631,000 | $82,683,000 |
| Total Equity Gross Minority Interest | $48,054,000 | $17,931,000 | $52,631,000 | $82,683,000 |
| Stockholders Equity | $48,054,000 | $17,931,000 | $52,631,000 | $82,683,000 |
| Retained Earnings | $-181,845,000 | $-145,428,000 | $-108,319,000 | $-75,974,000 |
| Other Equity Interest | - | - | - | $1,000 |
| Other | ||||
| Ordinary Shares Number | $44,628,832 | $30,184,388 | $30,184,188 | $30,184,388 |
| Share Issued | $44,628,832 | $30,184,388 | $30,184,188 | $30,184,388 |
| Tangible Book Value | $37,629,000 | $8,127,000 | $42,473,000 | $72,654,000 |
| Invested Capital | $62,026,000 | $33,186,000 | $65,287,000 | $94,134,000 |
| Working Capital | $54,328,000 | $24,743,000 | $55,955,000 | $86,845,000 |
| Capital Lease Obligations | $1,115,000 | $1,619,000 | $1,721,000 | $2,214,000 |
| Total Capitalization | $62,026,000 | $33,186,000 | $65,287,000 | $94,134,000 |
| Additional Paid In Capital | $217,774,000 | $155,249,000 | $155,249,000 | $155,249,000 |
| Capital Stock | $5,355,000 | $3,622,000 | $3,622,000 | $3,622,000 |
| Common Stock | $5,355,000 | $3,622,000 | $3,622,000 | $3,622,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $3,999,000 | $2,081,000 | $1,121,000 | $1,388,000 |
| Long Term Capital Lease Obligation | $518,000 | $1,051,000 | $1,294,000 | $1,741,000 |
| Current Capital Lease Obligation | $597,000 | $568,000 | $427,000 | $473,000 |
| Goodwill | $1,962,000 | $1,845,000 | $1,902,000 | $1,702,000 |
| Net PPE | $1,526,000 | $2,092,000 | $2,096,000 | $2,380,000 |
| Accumulated Depreciation | $-1,344,000 | $-1,001,000 | $-773,000 | $-612,000 |
| Gross PPE | $2,870,000 | $3,093,000 | $2,869,000 | $2,992,000 |
| Machinery Furniture Equipment | $1,467,000 | $1,275,000 | $923,000 | $802,000 |
| Buildings And Improvements | $1,403,000 | $1,818,000 | $1,946,000 | $2,190,000 |
| Properties | $0 | $0 | $0 | $0 |
| Raw Materials | $102,000 | $0 | - | - |
| Other Short Term Investments | - | - | $20,000,000 | - |
| Other Properties | - | - | - | $2,190,000 |
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-31,913,000 | $-32,692,000 | $-27,102,000 | $-22,198,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-31,763,000 | $-32,270,000 | $-26,685,000 | $-19,874,000 |
| Investing Activities | ||||
| Capital Expenditure | $-150,000 | $-422,000 | $-417,000 | $-2,324,000 |
| Investing Cash Flow | $-150,000 | $19,578,000 | $-20,417,000 | $-2,324,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $70,000,000 | $0 | $0 | $80,106,000 |
| Financing Cash Flow | $62,560,000 | $813,000 | $-557,000 | $105,361,000 |
| Net Common Stock Issuance | $70,000,000 | $0 | $0 | $80,106,000 |
| Common Stock Issuance | $70,000,000 | $0 | $0 | $80,106,000 |
| Other | ||||
| Repayment Of Debt | $-15,255,000 | $0 | - | - |
| Issuance Of Debt | $14,116,000 | $1,292,000 | $0 | $30,000,000 |
| End Cash Position | $60,043,000 | $29,768,000 | $41,760,000 | $89,443,000 |
| Beginning Cash Position | $29,768,000 | $41,760,000 | $89,443,000 | $6,382,000 |
| Effect Of Exchange Rate Changes | $-372,000 | $-113,000 | $-24,000 | $-100,000 |
| Changes In Cash | $30,647,000 | $-11,879,000 | $-47,659,000 | $83,163,000 |
| Net Issuance Payments Of Debt | $-1,139,000 | $1,292,000 | $0 | $30,000,000 |
| Net Long Term Debt Issuance | $-1,139,000 | $1,292,000 | $0 | $30,000,000 |
| Long Term Debt Payments | $-15,255,000 | $0 | - | - |
| Long Term Debt Issuance | $14,116,000 | $1,292,000 | $0 | $30,000,000 |
| Net Investment Purchase And Sale | $0 | $20,000,000 | $-20,000,000 | $0 |
| Sale Of Investment | $0 | $20,000,000 | $0 | - |
| Purchase Of Investment | $0 | $0 | $-20,000,000 | $0 |
| Net Intangibles Purchase And Sale | $0 | $0 | $-31,000 | $-2,233,000 |
| Purchase Of Intangibles | $0 | $0 | $-31,000 | $-2,233,000 |
| Net PPE Purchase And Sale | $-150,000 | $-422,000 | $-386,000 | $-91,000 |
| Purchase Of PPE | $-150,000 | $-422,000 | $-386,000 | $-91,000 |
| Taxes Refund Paid | $-167,000 | $-106,000 | $-49,000 | $-14,000 |
| Interest Received Cfo | $686,000 | $916,000 | $15,000 | $0 |
| Interest Paid Cfo | $-1,762,000 | $-17,000 | $-262,000 | $-163,000 |
| Change In Working Capital | $456,000 | $-1,163,000 | $2,953,000 | $-261,000 |
| Change In Payable | $2,313,000 | $-1,654,000 | $2,813,000 | $2,097,000 |
| Change In Receivables | $-1,857,000 | $491,000 | $140,000 | $-2,358,000 |
| Other Non Cash Items | $1,045,000 | $808,000 | $1,616,000 | $5,711,000 |
| Stock Based Compensation | $2,720,000 | $2,564,000 | $1,691,000 | $8,564,000 |
| Depreciation And Amortization | $898,000 | $726,000 | $735,000 | $329,000 |
| Depreciation | $898,000 | $726,000 | $735,000 | $329,000 |
| Pension And Employee Benefit Expense | $126,000 | $76,000 | $154,000 | $246,000 |
| Net Income From Continuing Operations | $-35,765,000 | $-36,074,000 | $-33,538,000 | $-34,245,000 |
| Net Foreign Currency Exchange Gain Loss | - | - | $0 | $-43,000 |
| Other Cash Adjustment Outside Changein Cash | - | - | - | $-2,000 |